Compare NVMI & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVMI | FMS |
|---|---|---|
| Founded | 1993 | 1996 |
| Country | Israel | Germany |
| Employees | N/A | N/A |
| Industry | Electronic Components | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 14.2B |
| IPO Year | 2001 | N/A |
| Metric | NVMI | FMS |
|---|---|---|
| Price | $444.40 | $22.42 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $431.88 | $30.00 |
| AVG Volume (30 Days) | 320.7K | ★ 438.7K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.94 | $1.41 |
| Revenue Next Year | $19.53 | $4.11 |
| P/E Ratio | $56.79 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $154.00 | $20.96 |
| 52 Week High | $507.27 | $30.46 |
| Indicator | NVMI | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 46.65 |
| Support Level | $412.61 | $21.56 |
| Resistance Level | $480.71 | $24.08 |
| Average True Range (ATR) | 23.04 | 0.36 |
| MACD | -2.47 | 0.04 |
| Stochastic Oscillator | 41.13 | 47.81 |
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.